346 related articles for article (PubMed ID: 26597052)
21. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
[No Abstract] [Full Text] [Related]
22. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
Lee EJ; Song KH; Kim DL; Jang YM; Hwang TS; Kim SK
Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
[TBL] [Abstract][Full Text] [Related]
23. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
[TBL] [Abstract][Full Text] [Related]
24. The combination of BRAF
Li Q; Yang L; Lv J; Xu L; Zhang M; Li S
Endocrine; 2022 Dec; 78(3):507-516. PubMed ID: 36152114
[TBL] [Abstract][Full Text] [Related]
25. BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.
Li X; Li E; Du J; Wang J; Zheng B
Clin Endocrinol (Oxf); 2019 Dec; 91(6):834-841. PubMed ID: 31441082
[TBL] [Abstract][Full Text] [Related]
26. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
Yoo EY; Shin JH; Ko EY; Han BK
AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
[TBL] [Abstract][Full Text] [Related]
27. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
28. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
[TBL] [Abstract][Full Text] [Related]
29. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Zatelli MC; Trasforini G; Leoni S; Frigato G; Buratto M; Tagliati F; Rossi R; Cavazzini L; Roti E; degli Uberti EC
Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
[TBL] [Abstract][Full Text] [Related]
31. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.
Kwak JY; Kim EK; Kim JK; Han JH; Hong SW; Park TS; Choi JR
Head Neck; 2010 Apr; 32(4):490-8. PubMed ID: 19672964
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.
Park KS; Oh YL; Ki CS; Kim JW
J Mol Diagn; 2015 Jul; 17(4):431-7. PubMed ID: 25937618
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of thyroid imaging reporting and data system combined with BRAF
Wu L; Shu H; Chen W; Gao Y; Yuan Y; Li X; Lu W; Ye X; Deng H
Sci Rep; 2022 Apr; 12(1):5934. PubMed ID: 35395862
[TBL] [Abstract][Full Text] [Related]
34. Association between macrocalcification and papillary thyroid carcinoma and corresponding valuable diagnostic tool: retrospective study.
Ye M; Wu S; Zhou Q; Wang F; Chen X; Gong X; Wu W
World J Surg Oncol; 2023 May; 21(1):149. PubMed ID: 37194091
[TBL] [Abstract][Full Text] [Related]
35. The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.
Kowalska A; Kowalik A; Pałyga I; Walczyk A; Gąsior-Perczak D; Kopczyński J; Lizis-Kolus K; Szyska-Skrobot D; Hurej S; Radowicz-Chil A; Chodurska R; Wypiórkiewicz E; Chłopek M; Nowak E; Niemyska K; Góźdź S
Endokrynol Pol; 2016; 67(1):41-7. PubMed ID: 26884114
[TBL] [Abstract][Full Text] [Related]
36. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
Koh J; Choi JR; Han KH; Kim EK; Yoon JH; Moon HJ; Kwak JY
PLoS One; 2013; 8(5):e64505. PubMed ID: 23717622
[TBL] [Abstract][Full Text] [Related]
37. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
38. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
Sheng D; Yu X; Li H; Zhang M; Chen J
Medicine (Baltimore); 2021 Sep; 100(37):e27167. PubMed ID: 34664843
[TBL] [Abstract][Full Text] [Related]
39. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
[TBL] [Abstract][Full Text] [Related]
40. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]